<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Boroumand-Jazi R</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)</funding><pagination>e70123</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12848907</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(2)</volume><pubmed_abstract>Preliminary animal and human studies have shown that blood dihydrotestosterone concentrations are increased in males with alcohol use disorder, and 5α-reductase inhibitors, which decrease dihydrotestosterone concentrations, reduce alcohol consumption. To gain mechanistic insight, we studied the effects of reduced dihydrotestosterone concentrations following pharmacological 5α-reductase inhibition on alcohol cue-elicited brain activity and alcohol craving in males with problematic alcohol use. To this end, this randomized, placebo-controlled, crossover challenge experiment investigated associations between dihydrotestosterone concentrations and brain functional magnetic resonance imaging (fMRI) activity during exposure to visual alcohol cues and alcohol craving following a single dose of 5 </pubmed_abstract><journal>Addiction biology</journal><pubmed_title>Dihydrotestosterone and Finasteride Effects on Alcohol Cue-Elicited Brain Activity in Males With Heavy Episodic Drinking.</pubmed_title><pmcid>PMC12848907</pmcid><funding_grant_id>402170461 – TRR265</funding_grant_id><funding_grant_id>402170461 - TRR265</funding_grant_id><pubmed_authors>Tan H</pubmed_authors><pubmed_authors>Muhle C</pubmed_authors><pubmed_authors>Gerhardt S</pubmed_authors><pubmed_authors>Bach P</pubmed_authors><pubmed_authors>Beck A</pubmed_authors><pubmed_authors>Boroumand-Jazi R</pubmed_authors><pubmed_authors>Lenz B</pubmed_authors><pubmed_authors>Sommer WH</pubmed_authors><pubmed_authors>Kundlacz M</pubmed_authors><pubmed_authors>Muller CP</pubmed_authors><pubmed_authors>Reichl M</pubmed_authors><pubmed_authors>Hoffmann S</pubmed_authors><pubmed_authors>Wenger LP</pubmed_authors><pubmed_authors>Vollstadt-Klein S</pubmed_authors><pubmed_authors>Kiefer F</pubmed_authors><pubmed_authors>Reinhard I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dihydrotestosterone and Finasteride Effects on Alcohol Cue-Elicited Brain Activity in Males With Heavy Episodic Drinking.</name><description>Preliminary animal and human studies have shown that blood dihydrotestosterone concentrations are increased in males with alcohol use disorder, and 5α-reductase inhibitors, which decrease dihydrotestosterone concentrations, reduce alcohol consumption. To gain mechanistic insight, we studied the effects of reduced dihydrotestosterone concentrations following pharmacological 5α-reductase inhibition on alcohol cue-elicited brain activity and alcohol craving in males with problematic alcohol use. To this end, this randomized, placebo-controlled, crossover challenge experiment investigated associations between dihydrotestosterone concentrations and brain functional magnetic resonance imaging (fMRI) activity during exposure to visual alcohol cues and alcohol craving following a single dose of 5 </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-06-10T08:57:48.599Z</modification><creation>2026-06-10T03:11:29.421Z</creation></dates><accession>S-EPMC12848907</accession><cross_references><pubmed>41603384</pubmed><doi>10.1111/adb.70123</doi></cross_references></HashMap>